Cargando…

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma

BACKGROUND: Proficient mismatch repair (pMMR) colorectal adenocarcinoma (CRAC) metastasizes to a greater extent than MMR-deficient CRAC. Prognostic biomarkers are preferred in clinical practice. However, traditional biomarkers screened directly from sequencing are often not robust and thus cannot be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yixi, Li, Dehua, Chen, Yang, Lu, Yongping, Zhou, Fangbin, Li, Chunhong, Zeng, Zhipeng, Cai, Wanxia, Lin, Liewen, Li, Qiang, Ye, Mingjun, Dong, Jingjing, Yin, Lianghong, Tang, Donge, Zhang, Gong, Dai, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529276/ https://www.ncbi.nlm.nih.gov/pubmed/34692502 http://dx.doi.org/10.3389/fonc.2021.727752

Ejemplares similares

Comprehensive characterization of ubiquitinome of human colorectal cancer and identification of potential survival-related ubiquitination
por: Zhang, Wei, et al.
Publicado: (2022)

Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
por: Zhang, Wei, et al.
Publicado: (2021)

Co-occurrence of Protein Crotonylation and 2-Hydroxyisobutyrylation in the Proteome of End-Stage Renal Disease
por: Dong, Jingjing, et al.
Publicado: (2021)

Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer
por: Dai, Weier, et al.
Publicado: (2019)

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
por: Fu, Yu, et al.
Publicado: (2023)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer
por: Zhou, Fangbin, et al.
Publicado: (2020)

Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2021)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer
por: Wei Zhang, et al.
Publicado: (2022)

A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment
por: Jiang, Zhongji, et al.
Publicado: (2022)

Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients
por: Jin, Min, et al.
Publicado: (2022)

Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
por: Li, Shishi, et al.
Publicado: (2022)

Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease
por: Yang, Yan, et al.
Publicado: (2023)

Serum metabolomics analysis reveals metabolite profile and key biomarkers of idiopathic membranous nephropathy
por: Ye, Mingjun, et al.
Publicado: (2023)

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
por: Jimenez-Rodriguez, Rosa M., et al.
Publicado: (2020)

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer
por: dos Santos, Jennifer Thalita Targino, et al.
Publicado: (2023)

Integrated computer analysis and a self-built Chinese cohort study identified GSTM2 as one survival-relevant gene in human colon cancer potentially regulating immune microenvironment
por: Zhang, Wei, et al.
Publicado: (2022)

The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer
por: Yang, Zhiqian, et al.
Publicado: (2023)

Corrigendum to “The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer”
por: Yang, Zhiqian, et al.
Publicado: (2023)

A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
por: Zhu, Jiangpeng, et al.
Publicado: (2023)

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
por: Eppenberger, Manuela, et al.
Publicado: (2010)

Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
por: Swan, Rebecca, et al.
Publicado: (2016)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
por: Giacomelli, Mauro, et al.
Publicado: (2023)

Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment
por: Zhang, Wei, et al.
Publicado: (2022)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
por: Nehmé, A, et al.
Publicado: (1999)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
por: Liu, Shou-Sheng, et al.
Publicado: (2018)

Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
por: Hale, Vanessa L., et al.
Publicado: (2018)

Efficient engineering of chromosomal ribosome binding site libraries in mismatch repair proficient Escherichia coli
por: Oesterle, Sabine, et al.
Publicado: (2017)

Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus
por: Li, Yixi, et al.
Publicado: (2022)

NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human Kidney Cancer
por: Zhang, Qian, et al.
Publicado: (2022)

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
por: Li, Jinming, et al.
Publicado: (2023)

Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
por: Chen, Kuo-Hsing, et al.
Publicado: (2016)

Multi-Platform-Based Analysis Characterizes Molecular Alterations of the Nucleus in Human Colorectal Cancer
por: Zhang, Wei, et al.
Publicado: (2022)

Comprehensive Analysis of Differentially Expressed Long Noncoding RNA-mRNA in the Adenoma-Carcinoma Sequence of DNA Mismatch Repair Proficient Colon Cancer
por: Li, Wenkun, et al.
Publicado: (2021)

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2023)

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer
por: Rong, Yu-ming, et al.
Publicado: (2023)

Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden: A Case Report
por: Chen, Mengni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qvg6o23702apdtj16u6tanvmc4